Buscar
Mostrando ítems 1-10 de 4192
Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: A double-blind, randomised controlled trial
(Elsevier, 2014)
Neurocysticercosis causes a substantial burden of seizure disorders worldwide. Treatment with either praziquantel or albendazole has suboptimum efficacy. We aimed to establish whether combination of these drugs would ...
Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children
(Elsevier, 2013)
To determine the effect of bovine lactoferrin (bLF) on prevention of diarrhea in children...
One-year bleaching efficacy using two HP products with different pH: A double-blind randomized clinical trial
(Blackwell Publishing Ltd, 2019)
A double‐blind study with a new monodrug Kan Jang: Decrease of symptoms and improvement in the recovery from common colds
(1995)
In a placebo‐controlled double‐blind study, the therapeutic effect of Kan Jang tablets made from Andrographis paniculata (Barm. F.) (Ness) dried extract was tested in patients with common colds. The patients were divided ...
Ciprofloxacin for the treatment of cholera: A randomized, double-blind, controlled clinical trial of a single daily dose in peruvian adults
(Oxford University Press, 1995)
We conducted a randomized, double-blind clinical trial to compare ciprofloxacin (250 mg once a day for 3 days) with tetracycline (500 mg four times a day for 3 days) in terms of efficacy and safety in the treatment of ...
Why do some dietary migraine patients claim they get headaches from placebos?
(Blackwell Science LtdOxfordInglaterra, 2000)
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): A multicentre, double-blind, randomised, phase 2b dose-selection study
(Elsevier, 2014)
Clinical effectiveness of previous regimens to treat Plasmodium vivax infection have been hampered by compliance. We aimed to assess the dose–response, safety, and tolerability of single-dose tafenoquine plus 3-day chloroquine ...
Moclobemide and imipramine in chronic depression (dysthymia): An international double-blind, placebo-controlled trial
(1997)
An international, multicenter, placebo-controlled study was undertaken to determine the safety and antidepressant efficacy of moclobemide, a new reversible inhibitor of monoamine oxidase A, and imipramine in the treatment ...